Standard BioTools Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $249.8M | $271.9M | $30.0M |
| Jun 2022 | $167.3M | $441.1M | $74.4M |
| Sep 2022 | $166.4M | $414.9M | $60.2M |
| Dec 2022 | $160.5M | $390.3M | $81.3M |
| Mar 2023 | $157.6M | $371.7M | $113.7M |
| Jun 2023 | $158.0M | $355.8M | $142.3M |
| Sep 2023 | $159.8M | $339.3M | $79.7M |
| Dec 2023 | $159.9M | $323.1M | $51.7M |
| Mar 2024 | $200.4M | $777.7M | $287.1M |
| Jun 2024 | $198.5M | $708.7M | $269.8M |
| Sep 2024 | $192.2M | $681.5M | $210.6M |
| Dec 2024 | $140.6M | $612.3M | $166.7M |
| Mar 2025 | $125.0M | $579.6M | $150.9M |
| Jun 2025 | $132.4M | $557.0M | $158.6M |
| Sep 2025 | $140.0M | $539.6M | $129.4M |
| Dec 2025 | $143.5M | $567.8M | $120.9M |
| Mar 2026 | $78.0M | $639.1M | $265.8M |
| Jun 2026 | $87.2M | $627.2M | $270.0M |